Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hennig

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Electrophoresis|March 19, 2009
Conformational dynamics of DNA-electrophoresis on cationic membranesValentin Kahl, Martin Hennig, Berenike Maier, et al.
Lab on a Chip|October 14, 2009
Dynamic patterns in a supported lipid bilayer driven by standing surface acoustic wavesMartin Hennig, Jürgen Neumann, Achim Wixforth, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|November 15, 2011
DNA concentration modulation on supported lipid bilayers switched by surface acoustic wavesMartin Hennig, Manuel Wolff, Jürgen Neumann, et al.
Aktuelle Urologie|July 30, 2020
[Current practice patterns of perioperative cystectomy management in Germany: a questionnaire survey]Franz F Dressler, Serkan Dogan, Martin Hennig, et al.
Urologia Internationalis|March 7, 2018
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current PracticeSerkan Dogan, Martin Hennig, Tanja Frank, et al.
Oncotarget|July 16, 2016
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancerAndre R Jordan, Soum D Lokeshwar, Luis E Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder CancerSarrah L Hasanali, Daley S Morera, Ronny R Racine, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Electrophoresis|March 19, 2009
Conformational dynamics of DNA-electrophoresis on cationic membranesValentin Kahl, Martin Hennig, Berenike Maier, et al.
Lab on a Chip|October 14, 2009
Dynamic patterns in a supported lipid bilayer driven by standing surface acoustic wavesMartin Hennig, Jürgen Neumann, Achim Wixforth, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|November 15, 2011
DNA concentration modulation on supported lipid bilayers switched by surface acoustic wavesMartin Hennig, Manuel Wolff, Jürgen Neumann, et al.
Aktuelle Urologie|July 30, 2020
[Current practice patterns of perioperative cystectomy management in Germany: a questionnaire survey]Franz F Dressler, Serkan Dogan, Martin Hennig, et al.
Urologia Internationalis|March 7, 2018
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current PracticeSerkan Dogan, Martin Hennig, Tanja Frank, et al.
Oncotarget|July 16, 2016
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancerAndre R Jordan, Soum D Lokeshwar, Luis E Lopez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder CancerSarrah L Hasanali, Daley S Morera, Ronny R Racine, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, et al.
Pageof 1